21 – 30 of 166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival
(
- Contribution to journal › Article
-
Mark
Incidence and prevalence of systemic sclerosis globally : A comprehensive systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension : call for a refined assessment
(
- Contribution to journal › Article
-
Mark
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
(
- Contribution to journal › Article
-
Mark
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
(
- Contribution to journal › Article
-
Mark
Multiple manifestations of systemic sclerosis affect walk distance
(
- Contribution to journal › Letter
- 2020
-
Mark
Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
(
- Contribution to journal › Article
-
Mark
Type III, IV, and VI Collagens Turnover in Systemic Sclerosis – a Longitudinal Study
(
- Contribution to journal › Article
-
Mark
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
(
- Contribution to journal › Scientific review